Search research articles
Contact Us
Filters
Showing results (441-450 of 527) with videos related to
Page
of 53
Sort By:
Schizophrenia Research
|
December 27, 2012
Prospective memory performance in patients with drug-naïve, first-episode psychosis
Kaiming Zhuo, Yun Lu, Zhiliang Yang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 20, 2007
The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls
Ruth S Barr, Melissa A Culhane, Lindsay E Jubelt, et al.
Ophthalmology
|
August 31, 2014
The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study
Emily Y Chew, Matthew D Davis, Ronald P Danis, et al.
JAMA Cardiology
|
February 15, 2017
Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death
John Jeffrey Carr, David R Jacobs, James G Terry, et al.
Acta Psychiatrica Scandinavica
|
January 25, 2007
A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain
D C Henderson, X Fan, P M Copeland, et al.
Diabetes Care
|
March 1, 2006
Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA)
Alain G Bertoni, David C Goff, Ralph B D'Agostino, et al.
JACC. Heart Failure
|
September 8, 2014
Association of obesity in early adulthood and middle age with incipient left ventricular dysfunction and structural remodeling: the CARDIA study (Coronary Artery Risk Development in Young Adults)
Satoru Kishi, Anderson C Armstrong, Samuel S Gidding, et al.
Schizophrenia Research
|
June 7, 2008
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1
Jonathan M Meyer, Vicki G Davis, Joseph P McEvoy, et al.
Journal of Dual Diagnosis
|
August 14, 2012
Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial
Gladys N Pachas, Corinne Cather, Sarah A Pratt, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
June 7, 2006
Dietary intake profile of patients with schizophrenia
David C Henderson, Christina P Borba, Tara B Daley, et al.
Page
of 53
Search research articles
Search
Showing results (441-450 of 527) with videos related to
Sort By:
Page
of 53
Schizophrenia Research
|
December 27, 2012
Prospective memory performance in patients with drug-naïve, first-episode psychosis
Kaiming Zhuo, Yun Lu, Zhiliang Yang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 20, 2007
The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls
Ruth S Barr, Melissa A Culhane, Lindsay E Jubelt, et al.
Ophthalmology
|
August 31, 2014
The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study
Emily Y Chew, Matthew D Davis, Ronald P Danis, et al.
JAMA Cardiology
|
February 15, 2017
Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death
John Jeffrey Carr, David R Jacobs, James G Terry, et al.
Acta Psychiatrica Scandinavica
|
January 25, 2007
A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain
D C Henderson, X Fan, P M Copeland, et al.
Diabetes Care
|
March 1, 2006
Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA)
Alain G Bertoni, David C Goff, Ralph B D'Agostino, et al.
JACC. Heart Failure
|
September 8, 2014
Association of obesity in early adulthood and middle age with incipient left ventricular dysfunction and structural remodeling: the CARDIA study (Coronary Artery Risk Development in Young Adults)
Satoru Kishi, Anderson C Armstrong, Samuel S Gidding, et al.
Schizophrenia Research
|
June 7, 2008
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1
Jonathan M Meyer, Vicki G Davis, Joseph P McEvoy, et al.
Journal of Dual Diagnosis
|
August 14, 2012
Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial
Gladys N Pachas, Corinne Cather, Sarah A Pratt, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
June 7, 2006
Dietary intake profile of patients with schizophrenia
David C Henderson, Christina P Borba, Tara B Daley, et al.
Page
of 53